Suppr超能文献

小剂量重组人脑利钠肽持续静脉输注对老年脓毒症性心功能不全患者的作用

Roles of small-dose recombinant human brain natriuretic peptide without bolus in Chinese older patients with septic cardiac dysfunction.

作者信息

Zhang Yongyang, Zhang Ying, Li Xuling

机构信息

Emergency Department, Jining No. 1 People's Hospital, Jining, 272011, China.

Department of Surgery, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.

出版信息

Eur Geriatr Med. 2019 Oct;10(5):721-726. doi: 10.1007/s41999-019-00229-6. Epub 2019 Aug 29.

Abstract

PURPOSE

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. As one of the most common organs is affected by sepsis, cardiac dysfunction increases adverse prognosis. This study was designed to analyze the roles of small-dose recombinant human brain natriuretic peptide without bolus in Chinese older patients with septic cardiac dysfunction.

METHODS

This study recruited 250 Chinese older patients with sepsis cardiac dysfunction in intensive care unit. Participants were randomly allocated into the control group (n = 125) and recombinant human brain natriuretic peptide group (n = 125). The control group received early goal-directed therapy, and the recombinant human brain natriuretic peptide group received recombinant human brain natriuretic peptide therapy in addition to early goal-directed therapy.

RESULTS

There was no significant difference in medical histories, infection types, failing organs, mortality within 28 days [37 (29.6%) vs. 34 (27.2%)], intensive care unit stay [27 (21.6) vs. 22 (17.6)] and hospital stay [41 (32.8%) vs. 37 (29.6%)] between the control and recombinant human brain natriuretic peptide groups (P > 0.05 for all). Lengths of intensive care unit [16 (13-22) days] and hospital stay [25 (22-30) days] in the recombinant human brain natriuretic peptide group were significantly shorter than in the control group [21 (14-23) days; 27 (23-30) days; P < 0.05 for all]. There was no significant difference in mean daily Sequential Organ Failure Assessment score between the two groups (P > 0.05 for all). Cardiovascular and respiratory scores (P < 0.05 for all) but not other organ scores (P > 0.05 for all) were significantly lower in the recombinant human brain natriuretic peptide group than in the control group.

CONCLUSIONS

Small-dose recombinant human brain natriuretic peptide was unable to lower the mortality and improve the liver, renal, and coagulation functions, but able to shorten the length of hospital stay and improve the cardiovascular and respiratory functions in Chinese older patients with septic cardiac dysfunction.

摘要

目的

脓毒症是由宿主对感染的反应失调引起的危及生命的器官功能障碍。作为脓毒症最常累及的器官之一,心脏功能障碍会增加不良预后。本研究旨在分析小剂量无负荷量重组人脑利钠肽在中国老年脓毒症性心脏功能障碍患者中的作用。

方法

本研究纳入了250例入住重症监护病房的中国老年脓毒症性心脏功能障碍患者。参与者被随机分为对照组(n = 125)和重组人脑利钠肽组(n = 125)。对照组接受早期目标导向治疗,重组人脑利钠肽组在早期目标导向治疗的基础上接受重组人脑利钠肽治疗。

结果

对照组和重组人脑利钠肽组在病史、感染类型、衰竭器官、28天内死亡率[37例(29.6%)对34例(27.2%)]、重症监护病房住院时间[27天(21.6天)对22天(17.6天)]和住院时间[41例(32.8%)对37例(29.6%)]方面均无显著差异(所有P>0.05)。重组人脑利钠肽组的重症监护病房住院时间[16天(13 - 22天)]和住院时间[25天(22 - 30天)]显著短于对照组[21天(14 - 23天);27天(23 - 30天);所有P<0.05]。两组间每日序贯器官衰竭评估平均分无显著差异(所有P>0.05)。重组人脑利钠肽组的心血管和呼吸评分(所有P<0.05)显著低于对照组,但其他器官评分无显著差异(所有P>0.05)。

结论

小剂量重组人脑利钠肽不能降低中国老年脓毒症性心脏功能障碍患者的死亡率,也不能改善肝脏、肾脏和凝血功能,但能够缩短住院时间并改善心血管和呼吸功能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验